Louise Cohen
Family Medicine · Port Charlotte, FLNPI 1164405007
Payments from drug & device makers
Across 78 payments — averaging $16.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$296
- Novo Nordisk$168
- Pfizer$150
- Lilly USA, LLC$108
- AstraZeneca$88
- Merck$83
- plus $387 from 13 others
What the payments were for
- Food & beverage$1,280100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 15 | $296 |
| Novo Nordisk | 10 | $168 |
| Pfizer | 10 | $150 |
| Lilly USA, LLC | 7 | $108 |
| AstraZeneca | 7 | $88 |
| Merck | 6 | $83 |
| GSK | 5 | $71 |
| AbbVie | 3 | $63 |
| Vanda Pharmaceuticals Inc. | 3 | $55 |
| GE HealthCare | 3 | $41 |
| Sanofi-aventis U.S. LLC | 1 | $21 |
| Johnson & Johnson | 1 | $21 |
| Xeris Pharmaceuticals, Inc. | 1 | $21 |
| Seqirus USA Inc | 1 | $20 |
| Genentech USA, Inc. | 1 | $17 |
| Sanofi Pasteur Inc. | 1 | $16 |
| Mylan Specialty L.p. | 1 | $16 |
| Boehringer Ingelheim | 1 | $15 |
| Amgen | 1 | $11 |
How this compares
$1,280 in reported general payments places this provider in the 65th percentile of 7,282 family medicine providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 14 | $10,818 |
| Losartan Potassium | 40 | $465 |
| Pantoprazole Sodium | 24 | $192 |
| Donepezil Hcl | 24 | $148 |
| Amlodipine Besylate | 23 | $143 |
| Rosuvastatin Calcium | 16 | $130 |
| Potassium Chloride | 12 | $120 |
| Metoprolol Succinate | 12 | $118 |
| Sertraline Hcl | 13 | $114 |
| Metoprolol Tartrate | 15 | $105 |
| Spironolactone | 13 | $98 |
| Levothyroxine Sodium | 13 | $89 |
| Atorvastatin Calcium | 18 | $79 |
| Simvastatin | 12 | $61 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $150 | $10,81814 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 7,282 family medicine providers in Florida.
Other family medicine in Port Charlotte
- Hugh ColemanDaytona Beach$115.5M
- Alexander WhiteDaytona Beach$69.7M
- Ronald SurowitzJupiter$38.3M
- Bruce RankinDeland$36.7M
- Keila HooverMiami$33.7M
- John NardandreaOcala$30.8M
- Jorge CasoMiami$22.6M
- Sharrell CooperPalm Coast$16.9M
- Christopher GallowayMelbourne$15.6M
- Dario AltamiranoHialeah$15.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.